- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,434GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,434GBP
- Report
- May 2026
- 452 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 276 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 150 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 282 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 274 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,434GBP
- Report
- November 2025
- 200 Pages
Global
From €7012EUR$7,950USD£6,080GBP
- Report
- January 2026
- 185 Pages
Global
From €3969EUR$4,500USD£3,441GBP
- Report
- January 2026
- 180 Pages
Global
From €3969EUR$4,500USD£3,441GBP
- Report
- September 2025
- 185 Pages
Global
From €3969EUR$4,500USD£3,441GBP
- Report
- July 2025
- 350 Pages
Global
From €4365EUR$4,949USD£3,785GBP
- Report
- June 2025
- 200 Pages
Global
From €2460EUR$2,789USD£2,133GBP
- Report
- June 2025
- 400 Pages
Global
From €4365EUR$4,949USD£3,785GBP
- Report
- June 2025
- 400 Pages
Global
From €4365EUR$4,949USD£3,785GBP
- Report
- October 2025
- 138 Pages
Global
From €3527EUR$3,999USD£3,058GBP
- Report
- January 2026
- 120 Pages
Global
From €4190EUR$4,750USD£3,633GBP
- Report
- December 2025
- 150 Pages
Global
From €4278EUR$4,850USD£3,709GBP
- Report
- November 2025
- 150 Pages
Global
From €4278EUR$4,850USD£3,709GBP

The Arthritis Drug market is a subset of the Immune Disorders Drugs market, which includes treatments for a variety of conditions related to the immune system. Arthritis drugs are used to treat the inflammation and pain associated with arthritis, a condition that affects the joints and surrounding tissues. These drugs can be divided into two main categories: non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs). NSAIDs are used to reduce inflammation and pain, while DMARDs are used to slow the progression of the disease.
The Arthritis Drug market is highly competitive, with a number of large pharmaceutical companies offering a variety of treatments. Some of the major players in the market include Pfizer, Merck, AbbVie, Johnson & Johnson, and Novartis. Show Less Read more